The Prognoses of Young Women With Breast Cancer (≤35 years) With Different Surgical Options: A Propensity Score Matching Retrospective Cohort Study.

However, the recurrence varied by biomarker subtype, and when examined over the full study period ( P = 0.056 and P = 0.014, respectively), these differences were borderline significant but leveled off after the introduction of trastuzumab after 2005 ( P = 0.24 and P = 0.42, respectively) ( 21 ).

also in 11,409 other papers